Health-Related Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Monica Bhatia(Columbia University Irving Medical Center), Stephen Sands(Columbia University Irving Medical Center), Laura Cimini(Columbia University), Prakash Satwani(Pediatrics and Genetics), Zhezhen Jin, Elissa Kolva(VA Eastern Colorado Health Care System), Mirko Savone(Columbia University Irving Medical Center), Courtney Briamonte(Columbia University Irving Medical Center), James H. Garvin(Columbia University Irving Medical Center), Mary Llenell Paz(Columbia University), Diane George(Columbia University Irving Medical Center), Eduvigis Cruz-Arrieta(Columbia University Irving Medical Center)
Cited by 84
Related Papers
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
|Gastroenterology|2020|261
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
|Journal of Clinical Oncology|1996|203
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
|Transplantation and Cellular Therapy|2020|201
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
|Journal of Clinical Oncology|1998|188
Evaluation of ChatGPT-generated medical responses: A systematic review and meta-analysis
|Journal of Biomedical Informatics|2024|181